Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Ogenix Corporation
WARNING LETTER
•Ogenix Corporation•March 1, 2012

Ogenix Corporation – FDA Warning Letter, Mar 1, 2012

Record Details

On March 27, 2012, the FDA issued a Warning Letter to Ogenix Corporation following an inspection from February 13 to March 1, 2012, at their Beachwood, Ohio facility. The inspection determined Ogenix is a specification developer for the EpiFLO topical oxygen system, classified as a device under 21 U.S.C. § 321(h). The devices were found to be adulterated under 21 U.S.C. § 351(h) due to non-conformity with Current Good Manufacturing Practice (CGMP) requirements of the Quality System regulation (21 C.F.R. Part 820).

Violations included: 1. Failure to establish and maintain procedures for purchased products and services (21 C.F.R. § 820.50), specifically not implementing the "Supplier Management Procedure" for critical suppliers and not including the membrane electrode assembly supplier on the approved list. 2. Failure to validate new EpiFLO designs (7-Day and 15-Day devices released August 2006) to ensure conformity to user/patient needs (21 C.F.R. § 820.30(g)). 3. Failure to adequately establish design inputs for device requirements, including strength and durability for devices worn 24/7,

Company
Ogenix Corporation
Inspection date
March 1, 2012
Product type
Devices
Office
Department of Health and Human Services
People
  • Paul J. Teitell (District Director)
  • Gina Brackett (Director of Compliance Branch)
View Company Profile

ID · 313cd07a-160a-41db-a2a0-d3fdf4a7bbd3

Violation Codes8
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.5021 CFR 820.30(g)21 CFR 820.30(c)21 CFR 820.30(i)21 CFR 820.100(a)(4)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ogenix Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.